nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0988	0.188	CbGbCtD
Doxazosin—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0988	0.188	CbGbCtD
Doxazosin—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0751	0.143	CbGbCtD
Doxazosin—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0751	0.143	CbGbCtD
Doxazosin—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0669	0.127	CbGbCtD
Doxazosin—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0415	0.079	CbGbCtD
Doxazosin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0354	0.0675	CbGbCtD
Doxazosin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0335	0.0637	CbGbCtD
Doxazosin—Donepezil—HTR2A—chronic obstructive pulmonary disease	0.00261	0.543	CrCbGaD
Doxazosin—Prazosin—CYP1A1—chronic obstructive pulmonary disease	0.0022	0.457	CrCbGaD
Doxazosin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.000926	CcSEcCtD
Doxazosin—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000378	0.000923	CcSEcCtD
Doxazosin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.000922	CcSEcCtD
Doxazosin—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000377	0.000921	CcSEcCtD
Doxazosin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.000913	CcSEcCtD
Doxazosin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000374	0.000913	CcSEcCtD
Doxazosin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.000912	CcSEcCtD
Doxazosin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000372	0.000907	CcSEcCtD
Doxazosin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.000907	CcSEcCtD
Doxazosin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.0009	CcSEcCtD
Doxazosin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.0009	CcSEcCtD
Doxazosin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.0009	CcSEcCtD
Doxazosin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000368	0.000899	CcSEcCtD
Doxazosin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.000897	CcSEcCtD
Doxazosin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.000895	CcSEcCtD
Doxazosin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000367	0.000895	CcSEcCtD
Doxazosin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.000891	CcSEcCtD
Doxazosin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000365	0.000891	CcSEcCtD
Doxazosin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.000889	CcSEcCtD
Doxazosin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000364	0.000889	CcSEcCtD
Doxazosin—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000364	0.000888	CcSEcCtD
Doxazosin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.000887	CcSEcCtD
Doxazosin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000364	0.000887	CcSEcCtD
Doxazosin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000362	0.000884	CcSEcCtD
Doxazosin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00088	CcSEcCtD
Doxazosin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000359	0.000876	CcSEcCtD
Doxazosin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.000876	CcSEcCtD
Doxazosin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000358	0.000874	CcSEcCtD
Doxazosin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000356	0.000869	CcSEcCtD
Doxazosin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.000862	CcSEcCtD
Doxazosin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.000857	CcSEcCtD
Doxazosin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00035	0.000854	CcSEcCtD
Doxazosin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00035	0.000854	CcSEcCtD
Doxazosin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000348	0.000849	CcSEcCtD
Doxazosin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.000849	CcSEcCtD
Doxazosin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.000847	CcSEcCtD
Doxazosin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.000842	CcSEcCtD
Doxazosin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.000838	CcSEcCtD
Doxazosin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000342	0.000834	CcSEcCtD
Doxazosin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.000834	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000341	0.000832	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.000832	CcSEcCtD
Doxazosin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000339	0.000826	CcSEcCtD
Doxazosin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.000826	CcSEcCtD
Doxazosin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.000822	CcSEcCtD
Doxazosin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000336	0.000821	CcSEcCtD
Doxazosin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000335	0.000818	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000334	0.000815	CcSEcCtD
Doxazosin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.000814	CcSEcCtD
Doxazosin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000334	0.000814	CcSEcCtD
Doxazosin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000333	0.000812	CcSEcCtD
Doxazosin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.000812	CcSEcCtD
Doxazosin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000332	0.000809	CcSEcCtD
Doxazosin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.000806	CcSEcCtD
Doxazosin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.000804	CcSEcCtD
Doxazosin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000329	0.000804	CcSEcCtD
Doxazosin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000329	0.000803	CcSEcCtD
Doxazosin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000328	0.000801	CcSEcCtD
Doxazosin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000326	0.000795	CcSEcCtD
Doxazosin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.000794	CcSEcCtD
Doxazosin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000324	0.000792	CcSEcCtD
Doxazosin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000323	0.000788	CcSEcCtD
Doxazosin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000323	0.000788	CcSEcCtD
Doxazosin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.000788	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.000786	CcSEcCtD
Doxazosin—Pain—Formoterol—chronic obstructive pulmonary disease	0.00032	0.000781	CcSEcCtD
Doxazosin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.000781	CcSEcCtD
Doxazosin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00032	0.000781	CcSEcCtD
Doxazosin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.000781	CcSEcCtD
Doxazosin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00078	CcSEcCtD
Doxazosin—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000319	0.000778	CcSEcCtD
Doxazosin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000319	0.000778	CcSEcCtD
Doxazosin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.000774	CcSEcCtD
Doxazosin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000316	0.000771	CcSEcCtD
Doxazosin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.000769	CcSEcCtD
Doxazosin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.000767	CcSEcCtD
Doxazosin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000314	0.000765	CcSEcCtD
Doxazosin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000313	0.000765	CcSEcCtD
Doxazosin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.000763	CcSEcCtD
Doxazosin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000312	0.00076	CcSEcCtD
Doxazosin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.000759	CcSEcCtD
Doxazosin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000759	CcSEcCtD
Doxazosin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.000757	CcSEcCtD
Doxazosin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.000756	CcSEcCtD
Doxazosin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000309	0.000754	CcSEcCtD
Doxazosin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.000753	CcSEcCtD
Doxazosin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000308	0.000753	CcSEcCtD
Doxazosin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.000752	CcSEcCtD
Doxazosin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00075	CcSEcCtD
Doxazosin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000749	CcSEcCtD
Doxazosin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.000748	CcSEcCtD
Doxazosin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.000747	CcSEcCtD
Doxazosin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000306	0.000747	CcSEcCtD
Doxazosin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.000744	CcSEcCtD
Doxazosin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.000738	CcSEcCtD
Doxazosin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.000738	CcSEcCtD
Doxazosin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.0003	0.000732	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.0003	0.000731	CcSEcCtD
Doxazosin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.000726	CcSEcCtD
Doxazosin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000297	0.000726	CcSEcCtD
Doxazosin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000296	0.000722	CcSEcCtD
Doxazosin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000296	0.000722	CcSEcCtD
Doxazosin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.000722	CcSEcCtD
Doxazosin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.000722	CcSEcCtD
Doxazosin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000295	0.00072	CcSEcCtD
Doxazosin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.00072	CcSEcCtD
Doxazosin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000292	0.000714	CcSEcCtD
Doxazosin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000292	0.000713	CcSEcCtD
Doxazosin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000292	0.000713	CcSEcCtD
Doxazosin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000291	0.000711	CcSEcCtD
Doxazosin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.000711	CcSEcCtD
Doxazosin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.000709	CcSEcCtD
Doxazosin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.000709	CcSEcCtD
Doxazosin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00029	0.000707	CcSEcCtD
Doxazosin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00029	0.000707	CcSEcCtD
Doxazosin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000289	0.000706	CcSEcCtD
Doxazosin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.000705	CcSEcCtD
Doxazosin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000693	CcSEcCtD
Doxazosin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.000685	CcSEcCtD
Doxazosin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.000682	CcSEcCtD
Doxazosin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.000682	CcSEcCtD
Doxazosin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000276	0.000673	CcSEcCtD
Doxazosin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.000673	CcSEcCtD
Doxazosin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000275	0.000672	CcSEcCtD
Doxazosin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.000671	CcSEcCtD
Doxazosin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00067	CcSEcCtD
Doxazosin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000666	CcSEcCtD
Doxazosin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00027	0.000659	CcSEcCtD
Doxazosin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000269	0.000655	CcSEcCtD
Doxazosin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.000655	CcSEcCtD
Doxazosin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000265	0.000646	CcSEcCtD
Doxazosin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.000646	CcSEcCtD
Doxazosin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000645	CcSEcCtD
Doxazosin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000263	0.000642	CcSEcCtD
Doxazosin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000261	0.000636	CcSEcCtD
Doxazosin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.000635	CcSEcCtD
Doxazosin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000259	0.000633	CcSEcCtD
Doxazosin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.000625	CcSEcCtD
Doxazosin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000256	0.000625	CcSEcCtD
Doxazosin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.000622	CcSEcCtD
Doxazosin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.000619	CcSEcCtD
Doxazosin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000616	CcSEcCtD
Doxazosin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000251	0.000612	CcSEcCtD
Doxazosin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00061	CcSEcCtD
Doxazosin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000248	0.000604	CcSEcCtD
Doxazosin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.000604	CcSEcCtD
Doxazosin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000242	0.000592	CcSEcCtD
Doxazosin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000591	CcSEcCtD
Doxazosin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00059	CcSEcCtD
Doxazosin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000582	CcSEcCtD
Doxazosin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.000581	CcSEcCtD
Doxazosin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000238	0.000581	CcSEcCtD
Doxazosin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000236	0.000576	CcSEcCtD
Doxazosin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.000576	CcSEcCtD
Doxazosin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.000575	CcSEcCtD
Doxazosin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000236	0.000575	CcSEcCtD
Doxazosin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000575	CcSEcCtD
Doxazosin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.000572	CcSEcCtD
Doxazosin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000234	0.000572	CcSEcCtD
Doxazosin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000572	CcSEcCtD
Doxazosin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.000571	CcSEcCtD
Doxazosin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00057	CcSEcCtD
Doxazosin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00057	CcSEcCtD
Doxazosin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000233	0.000569	CcSEcCtD
Doxazosin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000231	0.000564	CcSEcCtD
Doxazosin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000231	0.000564	CcSEcCtD
Doxazosin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.000562	CcSEcCtD
Doxazosin—Depression—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000562	CcSEcCtD
Doxazosin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00056	CcSEcCtD
Doxazosin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000556	CcSEcCtD
Doxazosin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000552	CcSEcCtD
Doxazosin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.000548	CcSEcCtD
Doxazosin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.000547	CcSEcCtD
Doxazosin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.000545	CcSEcCtD
Doxazosin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000544	CcSEcCtD
Doxazosin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.000544	CcSEcCtD
Doxazosin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000543	CcSEcCtD
Doxazosin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000222	0.000543	CcSEcCtD
Doxazosin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.000543	CcSEcCtD
Doxazosin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00054	CcSEcCtD
Doxazosin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.000533	CcSEcCtD
Doxazosin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000531	CcSEcCtD
Doxazosin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.000525	CcSEcCtD
Doxazosin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000523	CcSEcCtD
Doxazosin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000515	CcSEcCtD
Doxazosin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000512	CcSEcCtD
Doxazosin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00051	CcSEcCtD
Doxazosin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000495	CcSEcCtD
Doxazosin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.000487	CcSEcCtD
Doxazosin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000483	CcSEcCtD
Doxazosin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.000478	CcSEcCtD
Doxazosin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000473	CcSEcCtD
Doxazosin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00047	CcSEcCtD
Doxazosin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000452	CcSEcCtD
Doxazosin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.000447	CcSEcCtD
Doxazosin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000447	CcSEcCtD
Doxazosin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000444	CcSEcCtD
Doxazosin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000443	CcSEcCtD
Doxazosin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00044	CcSEcCtD
Doxazosin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.000423	CcSEcCtD
Doxazosin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000415	CcSEcCtD
Doxazosin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000409	CcSEcCtD
Doxazosin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000408	CcSEcCtD
Doxazosin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000405	CcSEcCtD
Doxazosin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000397	CcSEcCtD
Doxazosin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000396	CcSEcCtD
Doxazosin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000395	CcSEcCtD
Doxazosin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000393	CcSEcCtD
Doxazosin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000387	CcSEcCtD
Doxazosin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000382	CcSEcCtD
Doxazosin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00038	CcSEcCtD
Doxazosin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000375	CcSEcCtD
Doxazosin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000375	CcSEcCtD
Doxazosin—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000374	CcSEcCtD
Doxazosin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00037	CcSEcCtD
Doxazosin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000364	CcSEcCtD
Doxazosin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000359	CcSEcCtD
Doxazosin—Infection—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000357	CcSEcCtD
Doxazosin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000354	CcSEcCtD
Doxazosin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000351	CcSEcCtD
Doxazosin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000349	CcSEcCtD
Doxazosin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000348	CcSEcCtD
Doxazosin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000343	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000328	CcSEcCtD
Doxazosin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000327	CcSEcCtD
Doxazosin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000325	CcSEcCtD
Doxazosin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000323	CcSEcCtD
Doxazosin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000316	CcSEcCtD
Doxazosin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000312	CcSEcCtD
Doxazosin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000312	CcSEcCtD
Doxazosin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000312	CcSEcCtD
Doxazosin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00031	CcSEcCtD
Doxazosin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.00031	CcSEcCtD
Doxazosin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000307	CcSEcCtD
Doxazosin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000296	CcSEcCtD
Doxazosin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000294	CcSEcCtD
Doxazosin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000294	CcSEcCtD
Doxazosin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000286	CcSEcCtD
Doxazosin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000284	CcSEcCtD
Doxazosin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000284	CcSEcCtD
Doxazosin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000265	CcSEcCtD
Doxazosin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000258	CcSEcCtD
Doxazosin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000254	CcSEcCtD
Doxazosin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000246	CcSEcCtD
Doxazosin—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.000238	CcSEcCtD
Doxazosin—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000229	CcSEcCtD
Doxazosin—Rash—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.000227	CcSEcCtD
Doxazosin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.28e-05	0.000226	CcSEcCtD
Doxazosin—Headache—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.000225	CcSEcCtD
Doxazosin—Nausea—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000214	CcSEcCtD
Doxazosin—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.31e-05	0.00121	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.23e-05	0.0012	CbGpPWpGaD
Doxazosin—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.21e-05	0.0012	CbGpPWpGaD
Doxazosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	7.19e-05	0.00119	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.14e-05	0.00119	CbGpPWpGaD
Doxazosin—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.09e-05	0.00118	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.04e-05	0.00117	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.99e-05	0.00116	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.99e-05	0.00116	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.96e-05	0.00116	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.94e-05	0.00115	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.82e-05	0.00113	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	6.75e-05	0.00112	CbGpPWpGaD
Doxazosin—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.72e-05	0.00112	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.71e-05	0.00111	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.63e-05	0.0011	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.63e-05	0.0011	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.49e-05	0.00108	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	6.42e-05	0.00107	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	6.34e-05	0.00105	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.34e-05	0.00105	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.29e-05	0.00104	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	6.25e-05	0.00104	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	6.22e-05	0.00103	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	6.05e-05	0.00101	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.96e-05	0.00099	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.89e-05	0.000979	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.88e-05	0.000976	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.81e-05	0.000964	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.76e-05	0.000956	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	5.75e-05	0.000954	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	5.74e-05	0.000952	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	5.74e-05	0.000952	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	5.71e-05	0.000949	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.63e-05	0.000935	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.59e-05	0.000928	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.57e-05	0.000924	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.5e-05	0.000914	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.5e-05	0.000912	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	5.46e-05	0.000906	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.41e-05	0.000898	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.38e-05	0.000893	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	5.35e-05	0.000888	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	5.33e-05	0.000886	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.31e-05	0.000881	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.23e-05	0.000869	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.19e-05	0.000862	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.11e-05	0.000849	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.08e-05	0.000844	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.97e-05	0.000825	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.95e-05	0.000821	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.89e-05	0.000811	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.79e-05	0.000796	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.75e-05	0.000789	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.63e-05	0.000769	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.6e-05	0.000763	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.54e-05	0.000754	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.46e-05	0.000741	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.41e-05	0.000732	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.35e-05	0.000723	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.28e-05	0.000711	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.22e-05	0.000701	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.19e-05	0.000696	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.1e-05	0.00068	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.1e-05	0.00068	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4.08e-05	0.000677	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.98e-05	0.00066	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.96e-05	0.000658	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.95e-05	0.000656	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.91e-05	0.00065	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.9e-05	0.000648	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.89e-05	0.000646	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.89e-05	0.000646	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.86e-05	0.000641	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.83e-05	0.000636	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.8e-05	0.000631	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.79e-05	0.000629	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.75e-05	0.000622	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.75e-05	0.000622	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.7e-05	0.000614	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.68e-05	0.000612	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	3.63e-05	0.000602	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.61e-05	0.0006	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.58e-05	0.000595	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.55e-05	0.00059	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.53e-05	0.000587	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.52e-05	0.000585	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.52e-05	0.000584	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.48e-05	0.000578	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.48e-05	0.000578	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.44e-05	0.000571	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.4e-05	0.000565	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.4e-05	0.000565	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.4e-05	0.000564	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.39e-05	0.000562	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.28e-05	0.000545	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.24e-05	0.000538	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.23e-05	0.000536	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.21e-05	0.000533	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.16e-05	0.000524	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.11e-05	0.000516	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.07e-05	0.00051	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.02e-05	0.000502	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.02e-05	0.000501	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.01e-05	0.000499	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3e-05	0.000497	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.98e-05	0.000495	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.96e-05	0.000492	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	2.96e-05	0.000491	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.95e-05	0.000489	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.93e-05	0.000487	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.92e-05	0.000485	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	2.89e-05	0.000479	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.87e-05	0.000476	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.83e-05	0.00047	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.82e-05	0.000469	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.82e-05	0.000468	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.81e-05	0.000466	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.81e-05	0.000466	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.81e-05	0.000466	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.79e-05	0.000463	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.76e-05	0.000459	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.76e-05	0.000459	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.66e-05	0.000442	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	2.63e-05	0.000437	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.63e-05	0.000437	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.57e-05	0.000427	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.57e-05	0.000426	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.51e-05	0.000416	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.49e-05	0.000413	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.43e-05	0.000403	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.33e-05	0.000387	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.32e-05	0.000385	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.31e-05	0.000384	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.31e-05	0.000384	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.3e-05	0.000381	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.21e-05	0.000367	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.13e-05	0.000354	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.000349	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.09e-05	0.000347	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.07e-05	0.000344	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.05e-05	0.000341	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.05e-05	0.000341	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.05e-05	0.00034	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.04e-05	0.000338	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.02e-05	0.000336	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.02e-05	0.000335	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.01e-05	0.000334	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	2e-05	0.000331	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2e-05	0.000331	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.92e-05	0.000319	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.91e-05	0.000317	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.91e-05	0.000317	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.91e-05	0.000317	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000316	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.9e-05	0.000315	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.000312	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.87e-05	0.00031	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.87e-05	0.00031	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.00031	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.86e-05	0.000309	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.82e-05	0.000302	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.77e-05	0.000294	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	0.000293	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.76e-05	0.000292	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.74e-05	0.00029	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.73e-05	0.000288	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	0.000286	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.000285	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.000283	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.69e-05	0.000281	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.000279	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.67e-05	0.000277	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.000263	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000263	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.57e-05	0.000261	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.55e-05	0.000257	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.55e-05	0.000257	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	1.54e-05	0.000256	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.54e-05	0.000256	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.54e-05	0.000255	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.48e-05	0.000246	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.47e-05	0.000243	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.44e-05	0.000239	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.43e-05	0.000238	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.43e-05	0.000237	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.41e-05	0.000235	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.4e-05	0.000232	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.000232	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.000229	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.38e-05	0.000229	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.000229	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000219	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.32e-05	0.000219	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000216	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000214	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.28e-05	0.000212	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.27e-05	0.000212	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000207	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.000206	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000202	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.22e-05	0.000202	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000201	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	1.2e-05	0.000199	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.18e-05	0.000196	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.16e-05	0.000193	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000191	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	1.15e-05	0.00019	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.13e-05	0.000188	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.12e-05	0.000186	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.08e-05	0.000179	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.05e-05	0.000175	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.03e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.03e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.01e-05	0.000167	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1e-05	0.000167	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.8e-06	0.000163	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.59e-06	0.000159	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.32e-06	0.000155	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.26e-06	0.000154	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.15e-06	0.000152	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.07e-06	0.000151	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.7e-06	0.000145	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.5e-06	0.000141	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	8.49e-06	0.000141	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.37e-06	0.000139	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	8.29e-06	0.000138	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.28e-06	0.000137	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	8.12e-06	0.000135	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.09e-06	0.000134	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.93e-06	0.000132	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	7.81e-06	0.00013	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.69e-06	0.000128	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.68e-06	0.000128	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.62e-06	0.000127	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.53e-06	0.000125	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.47e-06	0.000124	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.43e-06	0.000123	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.97e-06	0.000116	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.91e-06	0.000115	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.82e-06	0.000113	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.69e-06	0.000111	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.34e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.32e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.22e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.79e-06	9.61e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.62e-06	9.33e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.22e-06	8.67e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.14e-06	8.54e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.78e-06	7.93e-05	CbGpPWpGaD
